"1"^^ . "2008-01-01+01:00"^^ . . "0"^^ . "2"^^ . "2"^^ . "Hodnocen\u00ED v\u00FDsledk\u016F \u0159e\u0161en\u00ED ministerstvo neprov\u00E1d\u00ED, nebo\u0165 podm\u00EDnkou podpory je, \u017Ee uchaze\u010D byl vybr\u00E1n mezin\u00E1rodn\u00EDm poskytovatelem v souladu s pravidly p\u0159\u00EDslu\u0161n\u00E9ho programu. Projekt je hodnocen a\u017E po jeho schv\u00E1len\u00ED mezin\u00E1rodn\u00EDm poskytovatelem."@cs . . " GBS" . . "Vaccine; GBS; Streptococcos; Newborns; Passive immunisations"@en . "Direct vaccination cannot prevent diseases that affect neonates in the first days of live. Group B Streptococcus (GBS) is the major cause of neonatal septicemia nd meningitis affecting up to one in every thousand live births. Over 80% of cases occur in the first 7 days after birth and the remaining 20% of disease occurs between 8-90 days after birth. Studies carried out in the USA indicate that high titres of maternal antibody to GBS capsular polysaccharides (CPS) correlate with reduced risk of diseases in neonates suggesting that maternal immunization may be an effective strategy for delivery of a protective immune response to the child in this early period. The overall objective of this proposal is to design immunization strategies capable of inducing strong durable and placentally transferable protective immune responses agains GBS in women in order to fill this gap in early infancy when direct immunization is not possible.Starting with the genome sequenceof 8 strains of GBS, Novartis scientist"@en . "2010-04-27+02:00"^^ . . . "Desing of a vaccine to immunize neonates against GBS infections through a durable maternal immune response"@en . . "7E08043" . . " Streptococcos" . . "Direct vaccination cannot prevent diseases that affect neonates in the first days of live. Group B Streptococcus (GBS) is the major cause of neonatal septicemia nd meningitis affecting up to one in every thousand live births. Over 80% of cases occur in the first 7 days after birth and the remaining 20% of disease occurs between 8-90 days after birth. Studies carried out in the USA indicate that high titres of maternal antibody to GBS capsular polysaccharides (CPS) correlate with reduced risk of diseases in neonates suggesting that maternal immunization may be an effective strategy for delivery of a protective immune response to the child in this early period. The overall objective of this proposal is to design immunization strategies capable of inducing strong durable and placentally transferable protective immune responses agains GBS in women in order to fill this gap in early infancy when direct immunization is not possible.Starting with the genome sequenceof 8 strains of GBS, Novartis scientist" . . "Vaccine" . . . . . . . " Newborns" . "Desing of a vaccine to immunize neonates against GBS infections through a durable maternal immune response" . . "2010-12-31+01:00"^^ . . . "http://www.isvav.cz/projectDetail.do?rowId=7E08043"^^ . "Following the condition that the candidate of financial contribution was evaluated and afterwards selected by international provider in accordance with the rules of the program the Ministry of Education, Youth ans Sports does not realize the evaluation of project results. The project is evaluated only after its approval by an international provider"@en . "2011-06-30+02:00"^^ . . . "0"^^ .